SECTION 1: CLINICAL
SECTION 2: DIAGNOSIS
SECTION 3: TENECTEPLASE (TNK) AND CLOT TREATMENT
SECTION 4: NOACs IN CLOT TREATMENT
SECTION 5: THROMBOSIS AND CORONARY ARTERY DISEASE
SECTION 6: THROMBOSIS AND HYPERTENSION
SECTION 7: THROMBOSIS AND HEART FAILURE
SECTION 8: THROMBOSIS AND DYSLIPIDEMIA
SECTON 9: THROMBOSIS AND DIABETES MELLITUS
SECTION 10: THROMBOSIS AND ARRHYTHMIA
SECTION 11: THROMBOSIS AND CARDIOMYOPATHY
SECTION 12: THROMBOSIS AND RHD
SECTION 13: DVT
SECTION 14: THROMBOSIS AND PAD
SECTION 15: THROMBOSIS AND CAROTID ARTERY DISEASE
SECTION 16: THROMBOSIS AND VERTEBRAL ARTERY DISEASE
SECTION 17: THROMBOSIS AND STROKE INTRACEREBRAL ARTERIAL DISEASE
SECTION 18: THROMBOSIS AND KIDNEY
SECTION 19: THROMBOSIS AND CARDIAC SURGERY
SECTION 20: THROMBOSIS AND CRITICAL CARE
SECTION 21: THROMBOSIS IN EMERGENCY AND URGENT CARE
SECTION 22: THROMBOSIS AND SEPSIS
SECTION 23: THROMBOSIS AND WOMEN
SECTION 24: THROMBOSIS AND EYE
SECTION 25: THROMBOSIS AND LUNG
SECTION 26: NOAC AND DRUGS INTERACTION
SECTION 27: COVID-INFLICTED COAGULOPATHY
SECTION 28: CLOT IN ECMO
SECTION 29: THROMBOSIS AND COVID VACCINATION
SECTION 30: THROMBOSIS AND NUTRITION
SECTION 31: CARDIO-ONCOLOGY AND THROMBOSIS
SECTION 32: POSTMITRAL CLIP THROMBOSIS
SECTION 33: PEDIATRICS AND THROMBOSIS
SECTION 34: SKIN AND THROMBOSIS
SECTION 35: THROMBOSIS AND AVN
SECTION 36: FUTURE DIRECTIONS IN THROMBOSIS CARE